vimarsana.com

Latest Breaking News On - Antimicrobial resistance conference - Page 1 : vimarsana.com

Acurx Pharmaceuticals, Inc Reports Third Quarter 2022 Results and Provides Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United statesRobertg shawahDavidp luciPrnewswire acurx pharmaceuticals incDrug administrationExchange commissionExchange commission on formAcurx pharmaceuticalsAnaerobe society of americaAcurx pharmaceuticals incLeiden university medical center hollandUniversity of houstonLeiden university medical centerAnaerobe societyAntimicrobial resistance conferenceChief executive officer

Acurx Pharmaceuticals, Inc Reports Second Quarter 2022 Results and Provides Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United statesRobertg shawahDavidp luciPaycheck protection program loanPrnewswire acurx pharmaceuticals incDrug administrationExchange commissionC diff foundation conferenceExchange commission on formAcurx pharmaceuticalsAnaerobe society of americaAcurx pharmaceuticals incLeiden university medical center hollandUniversity of houstonLeiden university medical centerAnaerobe society

vimarsana © 2020. All Rights Reserved.